This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Divine Skin Signs Letter Of Intent To Acquire Its Mexican Distributor

MIAMI BEACH, Fla., March 22, 2012 /PRNewswire/ -- Today Divine Skin Inc., (OTC Bulletin Board: DSKX),  a leading developer of cutting-edge biotechnology for hair and skin, announced that it had signed a letter of intent to acquire 100 percent of Divine Skin Laboratories SA de CV in stock. In 2011, the Mexican company represented nearly 10 percent of Divine Skin's revenue. It has been a distributor of Divine Skin product for more than three years, with sales growing quickly year over year.

Divine Skin CEO Daniel Khesin stated, "I believe this move will not only boost our current revenue but also be a significant asset to Divine Skin's human resources. We've worked with Divine Skin Laboratories SA de CV for many years, and it has proven to be a very strong partner. We value this relationship, and I know that this acquisition will add significant value to both entities."

In Mexico, Fernando Tamez, CEO of Divine Skin Laboratories SA de CV, said, "I'm thrilled to take a more active role in Divine Skin Inc. I started the distribution of DS Laboratories products three years ago and have seen this market grow into a sizable revenue stream, with enormous continued upside for growth. I think we can continue to double our revenues every year for the next few years. Mexico is a huge market for these advanced products. Divine Skin offers formulas unlike anything else we have in Mexico, and I am looking forward to continuing to expand this business."

The terms of the agreement will be made public once the transaction is complete. It is scheduled to close in the second quarter of 2012.

About Divine Skin Laboratories SA de CV

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs